| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.8K | $3.82M | - | |
| Other | 133.1K | $3.44M | - | |
| CEO | 132.7K | $3.43M | - | |
| CFO | 105.7K | $2.73M | - | |
| VP | 95.7K | $2.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2020 | Kakkis Emil D72 | President &CEO | Sell | 30,000 | $82.63 | $2,478,900.00 | -1.2% | |
| Aug 21, 2020 | Aliski William | Director | Sale+OE | 5,000 | $86.57 | $432,850.00 | -8.1% | |
| Aug 17, 2020 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 14,378 | $88.40 | $1,271,072.70 | -2.8% | |
| Aug 17, 2020 | Parschauer Karah Herdman77 | EVP And General Counsel | Sale+OE | 12,370 | $88.43 | $1,093,884.30 | -19.5% | |
| Aug 10, 2020 | Siegall Clay B77 | Director | Sale+OE | 34,750 | $85.37 | $2,966,735.66 | -66.6% | |
| Jul 13, 2020 | Kakkis Emil D72 | President &CEO | Sell | 40,000 | $85.35 | $3,414,000.00 | -1.6% | |
| Jul 8, 2020 | Huizenga Theodore Alan65 | SVP, Controller And Pao | Sale+OE | 2,638 | $91.00 | $240,058.00 | -7.4% | |
| Jul 6, 2020 | Fust Matthew K77 | Director | Sale+OE | 6,181 | $90.00 | $556,290.00 | -31.3% | |
| Jul 1, 2020 | Huizenga Theodore Alan65 | SVP, Controller And Pao | Sale+OE | 2,611 | $81.00 | $211,491.00 | -7.0% | |
| Jul 1, 2020 | Fust Matthew K77 | Director | Sale+OE | 5,000 | $85.00 | $425,000.00 | -27.0% |